Boston Scientific (BSX) to benefit from Olympus import warning - BofA Securities
Tweet Send to a Friend
BofA Securities analyst Travis Steed reiterated a Buy rating and $115.00 price target on Boston Scientific (NYSE: BSX) saying it ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
